Strengthen the Core℠
Aesthetic Marketing and Practice Management Consulting℠

Steven Fagien MD FACS

Medical Director, Steven Fagien MD FACS

Steven Fagien MD FACS

Medical Director, Steven Fagien MD FACS
(561) 393-9898

Biography

Dr Steven Fagien is in private surgical practice in Boca Raton, Florida. He earned his medical degree and completed his residency in ophthalmology from the University of Florida College of Medicine in Gainesville, Florida, and completed a fellowship in ophthalmic plastic and reconstructive surgery at the University of Illinois Eye and Ear Infirmary in Chicago, Illinois.

In addition to his extensive organizational and volunteer involvement, Dr Fagien is a member of numerous professional organizations that span the specialties of Ophthalmology, Plastic Surgery and Dermatology, including the American Society of Ophthalmic Plastic and Reconstructive Surgery, the American Society of Aesthetic Plastic Surgery, and the American Society of Dermatological Surgeons. His areas of expertise are in aesthetic eyelid plastic surgery, advanced applications of BOTOX® for facial aesthetic enhancement, and various forms of injectable agents for soft tissue contouring and augmentation..

Dr Fagien has more than 30 years of experience with Botulinum toxin type A, and pioneered, instituted and instructs courses on the various uses of BOTOX® as well as injectable agents in facial aesthetics, for esteemed societies such as the American Society of Plastic Surgery and the American Society of Aesthetic Plastic Surgery. He continues to participate in FDA- and investigator-initiated clinical trials using Botulinum toxin type A for expanded application in facial aesthetics along with a host of hyaluronic acid products and many other soft-tissue filling agents. He is a pioneer in the use of injectable soft tissue augmentation agents and was the founder of Collagenesis, Inc, and co-developer of injectable autologous and allogeneic human tissue collagen matrices (Autologen® and Dermalogen®) and an allogeneic surgically implantable human collagen matrix (Dermaplant®). Dr. Fagien was involved early on with the development of ATX-101 (now called Kybella®) and was an clinical investigator and consultant leading to the FDA approval of Kybella®. He also serves as a consultant and is a member of the medical advisory board to many of the world’s largest industry producers and distributors of injectable agents and plastic surgery products/devices as well as many multi-specialty advisory/consensus groups.

Dr Fagien has edited, authored, or contributed to more than 400 articles, abstracts, book chapters, and texts (including his latest text; the fourth edition of Putterman’s Cosmetic Oculoplastic Surgery. Elsevier Publishers 2008) and has made more than 600 presentations nationally and internationally. He has been profiled in numerous publications, including Allure, W, Vogue, OK, Tattler, and More, as well as Best Doctors in America. Recently, Dr Fagien was named one of W magazine’s world’s best plastic surgeons specializing in eyelids and as one of the nation’s best eyelid plastic surgeons by More magazine and The New York Times.